Activated Peripheral CD8 Lymphocytes Express CD4 In Vivo and Are Targets for Infection by Human Immunodeficiency Virus Type 1

ABSTRACT There is increasing evidence that CD8 lymphocytes may represent targets for infection by human immunodeficiency virus type 1 (HIV-1) in vivo whose destruction may contribute to the loss of immune function underlying AIDS. HIV-1 may infect thymic precursor cells destined to become CD4 and CD8 lymphocytes and contribute to the numerical decline in both subsets on disease progression. There is also evidence for the induction of CD4 expression and susceptibility to infection by HIV-1 of CD8 lymphocytes activated in vitro. To investigate the relationship between CD8 activation and infection by HIV-1 in vivo, activated subsets of CD8 lymphocytes in peripheral blood mononuclear cells (PBMCs) of HIV-seropositive individuals were investigated for CD4 expression and HIV infection. Activated CD8 lymphocytes were identified by expression of CD69, CD71, and the human leukocyte antigen (HLA) class II, the β-chain of CD8, and the RO isoform of CD45. CD4+ and CD4− CD8 lymphocytes, CD4 lymphocytes, other T cells, and non-T cells were purified using paramagnetic beads, and proviral sequences were quantified by PCR using primers from the long terminal repeat region. Frequencies of activated CD8 lymphocytes were higher in HIV-infected study subjects than in seronegative controls, and they frequently coexpressed CD4 (mean frequencies on CD69+, CD71+, and HLA class II+ cells of 23, 37, and 8%, respectively, compared with 1 to 2% for nonactivated CD8 lymphocytes). The level of CD4 expression of the double-positive population approached that of mature CD4 lymphocytes. That CD4 expression renders CD8 cell susceptible to infection was indicated by their high frequency of infection in vivo; infected CD4+ CD8 lymphocytes accounted for between 3 and 72% of the total proviral load in PBMCs from five of the eight study subjects investigated, despite these cells representing a small component of the PBMC population (<3%). Combined, these findings provide evidence that antigenic stimulation of CD8 lymphocytes in vivo induces CD4 expression that renders them susceptible to HIV infection and destruction. The specific targeting of responding CD8 lymphocytes may provide a functional explanation for the previously observed impairment of cytotoxic T-lymphocyte (CTL) function disproportionate to their numerical decline in AIDS and for the deletion of specific clones of CTLs responding to HIV antigens.

[1]  C. Leen,et al.  Infection of the CD45RA+ (Naive) Subset of Peripheral CD8+ Lymphocytes by Human Immunodeficiency Virus Type 1 In Vivo , 2001, Journal of Virology.

[2]  Christina M. R. Kitchen,et al.  Generation of HIV latency during thymopoiesis , 2001, Nature Medicine.

[3]  B. Zerhouni,et al.  Evidence of productively infected CD8+ T cells in patients with AIDS: implications for HIV-1 pathogenesis. , 2001, Journal of acquired immune deficiency syndromes.

[4]  B. Zerhouni,et al.  Isolation of primary HIV-1 that target CD8+ T Lymphocytes using CD8 as a receptor , 2001, Nature Medicine.

[5]  R. Yogev,et al.  Evaluation of thymopoiesis using T cell receptor excision circles (TRECs): differential correlation between adult and pediatric TRECs and naïve phenotypes. , 2000, Clinical immunology.

[6]  Yoshikawa,et al.  An African green monkey lacking peripheral CD4 lymphocytes that retains helper T cell activity and coexists with SIVagm , 1999, Clinical and experimental immunology.

[7]  Anthony S. Fauci,et al.  Both Memory and CD45RA+/CD62L+ Naive CD4+ T Cells Are Infected in Human Immunodeficiency Virus Type 1-Infected Individuals , 1999, Journal of Virology.

[8]  S. Riddell,et al.  The antiviral activity of HIV-specific CD8+ CTL clones is limited by elimination due to encounter with HIV-infected targets. , 1999, Journal of immunology.

[9]  R. Detels,et al.  The prognostic significance in HIV infection of immune activation represented by cell surface antigen and plasma activation marker changes. , 1999, Clinical immunology.

[10]  Spyros A. Kalams,et al.  The Critical Need for CD4 Help in Maintaining Effective Cytotoxic T Lymphocyte Responses , 1998, The Journal of experimental medicine.

[11]  A. Spurkland,et al.  Activation and proliferation of CD8+ T cells in lymphoid tissues of HIV-1-infected individuals in the absence of the high-affinity IL-2 receptor. , 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[12]  M. Roth,et al.  Costimulation of Naive CD8+ Lymphocytes Induces CD4 Expression and Allows Human Immunodeficiency Virus Type 1 Infection , 1998, Journal of Virology.

[13]  P. Gregersen,et al.  Apoptosis of CD8+ T cells is mediated by macrophages through interaction of HIV gp120 with chemokine receptor CXCR4 , 1998, Nature.

[14]  M. Sinet,et al.  Changes in blood CD8+ lymphocyte activation status and plasma HIV RNA levels during antiretroviral therapy , 1998, AIDS.

[15]  J. Moore,et al.  Expression patterns of the HIV type 1 coreceptors CCR5 and CXCR4 on CD4+ T cells and monocytes from cord and adult blood. , 1998, AIDS research and human retroviruses.

[16]  Carl H. June,et al.  Productive Infection of Neonatal Cd8 Ϩ T Lymphocytes by Hiv-1 , 2022 .

[17]  D. Margolis,et al.  Activation of CD8+ T lymphocytes through the T cell receptor turns on CD4 gene expression: implications for HIV pathogenesis. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[18]  M. Daucher,et al.  Evidence for rapid disappearance of initially expanded HIV-specific CD8+ T cell clones during primary HIV infection. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[19]  J. Zack,et al.  CXCR4 expression during lymphopoiesis: implications for human immunodeficiency virus type 1 infection of the thymus , 1997, Journal of virology.

[20]  M. Baseler,et al.  Human immunodeficiency virus type 1 infection of mature CD3hiCD8+ thymocytes , 1997, Journal of virology.

[21]  J. Zack,et al.  Mechanism of human immunodeficiency virus type 1 localization in CD4-negative thymocytes: differentiation from a CD4-positive precursor allows productive infection , 1997, Journal of virology.

[22]  R. Siliciano,et al.  Differential susceptibility of naive and memory CD4+ T cells to the cytopathic effects of infection with human immunodeficiency virus type 1 strain LAI , 1997, Journal of virology.

[23]  M. Roederer,et al.  HIV does not replicate in naive CD4 T cells stimulated with CD3/CD28. , 1997, The Journal of clinical investigation.

[24]  D. Richman,et al.  Preferential replication of HIV-1 in the CD45RO memory cell subset of primary CD4 lymphocytes in vitro. , 1997, The Journal of clinical investigation.

[25]  C. Mackay,et al.  The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[26]  F. Bushman,et al.  HIV-1 cDNA Integration: Requirement of HMG I(Y) Protein for Function of Preintegration Complexes In Vitro , 1997, Cell.

[27]  J. Benito,et al.  Quantitative alterations of the functionally distinct subsets of CD4 and CD8 T lymphocytes in asymptomatic HIV infection: changes in the expression of CD45RO, CD45RA, CD11b, CD38, HLA-DR, and CD25 antigens. , 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[28]  P. Simmonds,et al.  Frequent infection of peripheral blood CD8-positive T-lymphocytes with HIV-1 , 1996, The Lancet.

[29]  G. Reubel,et al.  Simian immunodeficiency virus infection of CD8+ lymphocytes in vivo , 1996, Journal of virology.

[30]  C. Broder,et al.  CC CKR5: A RANTES, MIP-1α, MIP-1ॆ Receptor as a Fusion Cofactor for Macrophage-Tropic HIV-1 , 1996, Science.

[31]  Virginia Litwin,et al.  HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5 , 1996, Nature.

[32]  Paul E. Kennedy,et al.  HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor , 1996, Science.

[33]  C. Broder,et al.  CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1. , 1996, Science.

[34]  B. Vandekerckhove,et al.  Characterization of distinct stages during the differentiation of human CD69+CD3+ thymocytes and identification of thymic emigrants. , 1995, Journal of immunology.

[35]  D. Cooper,et al.  Effects of primary HIV‐1 infection on subsets of CD4+ and CD8+ T lymphocytes , 1995, AIDS.

[36]  M. Roederer,et al.  CD8 naive T cell counts decrease progressively in HIV-infected adults. , 1995, The Journal of clinical investigation.

[37]  J. Margolick,et al.  CD8+ lymphocyte activation at human immunodeficiency virus type 1 seroconversion: development of HLA-DR+ CD38- CD8+ cells is associated with subsequent stable CD4+ cell levels. The Multicenter AIDS Cohort Study Group. , 1994, The Journal of infectious diseases.

[38]  J. Rodgers,et al.  Anergy and apoptosis in CD8+ T cells from HIV-infected persons. , 1994, Journal of immunology.

[39]  D. D. Des Jarlais,et al.  Syringe-mediated drug-sharing (backloading): a new risk factor for HIV among injecting drug users , 1993, AIDS.

[40]  M. Wainberg,et al.  Detection of unintegrated human immunodeficiency virus type 1 DNA in persistently infected CD8+ cells. , 1993, The Journal of general virology.

[41]  J. Giorgi,et al.  Circulating HIV-specific CD8+ cytotoxic T cells express CD38 and HLA-DR antigens. , 1993, Journal of immunology.

[42]  W. Cumberland,et al.  Immune changes in HIV-1 infection: significant correlations and differences in serum markers and lymphoid phenotypic antigens. , 1992, Clinical immunology and immunopathology.

[43]  J. Zack,et al.  Incompletely reverse-transcribed human immunodeficiency virus type 1 genomes in quiescent cells can function as intermediates in the retroviral life cycle , 1992, Journal of virology.

[44]  W. Cumberland,et al.  Eleven lymphoid phenotypic markers in HIV infection: selective changes induced by zidovudine treatment. , 1992, Journal of acquired immune deficiency syndromes.

[45]  D. Hafler,et al.  The coexpression of CD45RA and CD45RO isoforms on T cells during the S/G2/M stages of cell cycle. , 1991, Cellular immunology.

[46]  S. Meuer,et al.  Expression of different CD8 isoforms on distinct human lymphocyte subpopulations , 1991, European journal of immunology.

[47]  H. Spits,et al.  Comparative analysis of CD8 expressed on mature CD4+ CD8+ T cell clones cultured with IL-4 and that on CD8+ T cell clones: implication for functional significance of CD8 beta. , 1991, International immunology.

[48]  M. Stevenson,et al.  HIV‐1 replication is controlled at the level of T cell activation and proviral integration. , 1990, The EMBO journal.

[49]  Jerome A. Zack,et al.  HIV-1 entry into quiescent primary lymphocytes: Molecular analysis reveals a labile, latent viral structure , 1990, Cell.

[50]  D. Hafler,et al.  Frequency analysis of CD4+CD8+ T cells cloned with IL-4. , 1990, Cellular immunology.

[51]  P. Simmonds,et al.  Human immunodeficiency virus-infected individuals contain provirus in small numbers of peripheral mononuclear cells and at low copy numbers , 1990, Journal of virology.

[52]  H. Spits,et al.  Interleukin-4 mediates CDS induction on human CD4+ T-cell clones , 1988, Nature.

[53]  Robin A. Weiss,et al.  The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain , 1986, Cell.

[54]  Luc Montagnier,et al.  T-lymphocyte T4 molecule behaves as the receptor for human retrovirus  LAV , 1984, Nature.

[55]  M. Greaves,et al.  The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus , 1984, Nature.